Loading
Latest filing published 11 Feb 2019 for Histogen Inc., €3,579.
Daniel L. Ripley is a declared insider of Histogen Inc., with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 12 May 2017 and the latest from 14 November 2018.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 11 February 2019 with a share grant (€3,579) in Histogen Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations